XML 70 R60.htm IDEA: XBRL DOCUMENT
v3.23.1

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands |  |  | 1 Months Ended | 3 Months Ended |
--- | --- | --- | --- | --- | ---
Apr. 17, 2023 | May 05, 2021 | Dec. 31, 2021 | Mar. 31, 2023 | Dec. 31, 2022
Commitments And Contingencies Details [Line Items] |  |  |  |  |
Contingent consideration |  |  |  | $ 87,013 | $ 105,945
Accrued research and development software |  |  |  | 15,000 | 7,333
Evolution |  |  |  |  |
Commitments And Contingencies Details [Line Items] |  |  |  |  |
Sale of biomaterial products amount | $ 2,350 |  |  |  |
Sirion License |  |  |  |  |
Commitments And Contingencies Details [Line Items] |  |  |  |  |
Upfront fee |  |  | $ 136 |  |
Annual maintenance fee |  |  | 113 |  |
Clinical and regulatory milestones |  |  | $ 5,099 |  |
License agreement period |  |  | 10 years |  |
Notice period |  |  | 30 days |  |
Palantir Technologies, Inc | Master Subscription Agreement |  |  |  |  |
Commitments And Contingencies Details [Line Items] |  |  |  |  |
Payments for master subscription agreement |  | $ 40,000 |  |  |
Payment subscription period |  | 5 years |  |  |
Costs related to straight line basis agreement |  |  |  | 2,000 |
Accrued research and development software |  |  |  | 31,008 | 7,333
Palantir Technologies, Inc | Software cease-use Costs |  |  |  |  |
Commitments And Contingencies Details [Line Items] |  |  |  |  |
Exit or disposal costs |  |  |  | 23,675 |
Legacy Celularity | HLI Cellular Therapeutics, LLC | Anthrogenesis |  |  |  |  |
Commitments And Contingencies Details [Line Items] |  |  |  |  |
Contingent consideration |  |  |  | $ 87,013 | $ 105,945

X
- Definition Accrued research and development software. + References No definition available. + Details
Name: | celu_AccruedResearchAndDevelopmentSoftware
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Annual maintenance fee. + References No definition available. + Details
Name: | celu_AnnualMaintenanceFee
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Clinical and regulatory milestones. + References No definition available. + Details
Name: | celu_ClinicalAndRegulatoryMilestones
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Commitments and contingencies (Details) [Line Items] + References No definition available. + Details
Name: | celu_CommitmentsAndContingenciesDetailsLineItems
Namespace Prefix: | celu_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition License agreement notice period. + References No definition available. + Details
Name: | celu_LicenseAgreementNoticePeriod
Namespace Prefix: | celu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payment subscription period. + References No definition available. + Details
Name: | celu_PaymentSubscriptionPeriod
Namespace Prefix: | celu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments for master subscription agreement. + References No definition available. + Details
Name: | celu_PaymentsForMasterSubscriptionAgreement
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sale of biomaterial products amount. + References No definition available. + Details
Name: | celu_SaleOfBiomaterialProductsAmount
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront fee. + References No definition available. + Details
Name: | celu_UpfrontFee
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 + Details
Name: | us-gaap_BusinessExitCosts1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Costs of sales and operating expenses for the period incurred from transactions with related parties. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_CostsAndExpensesRelatedParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_LongtermPurchaseCommitmentPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=celu_EvolutionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=celu_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=celu_PalantirTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=celu_MasterSubscriptionAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=celu_SoftwareCeaseUseCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=celu_LegacyCelularitysMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=celu_HLICellularTherapeuticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=celu_LLCAndAnthrogenesisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |